Gufic Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 2,148.74 million compared to INR 1,748.35 million a year ago. Revenue was INR 2,152.09 million compared to INR 1,756.54 million a year ago. Net income was INR 232.1 million compared to INR 202.12 million a year ago. Basic earnings per share from continuing operations was INR 2.39 compared to INR 2.09 a year ago. Diluted earnings per share from continuing operations was INR 2.39 compared to INR 2.09 a year ago.
For the six months, sales was INR 4,098.94 million compared to INR 3,401.12 million a year ago. Revenue was INR 4,107.67 million compared to INR 3,413.05 million a year ago. Net income was INR 438.33 million compared to INR 412.63 million a year ago. Basic earnings per share from continuing operations was INR 4.52 compared to INR 4.26 a year ago. Diluted earnings per share from continuing operations was INR 4.52 compared to INR 4.26 a year ago.